Adversity, Brain and Opioid Use Study
University of Michigan · with National Institute on Drug Abuse (NIDA) · NCT06355778
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–55 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 185
- US sites recruiting
- 1
- Study start
- January 9, 2025
- Record last updated
- July 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The way people process and remember information may be related to adverse childhood experiences and Opioid Use Disorder symptoms. The purpose of this project is to examine brain function and performance during learning and memory tasks in adults. The study will compare measures of learning and memory across three groups of participants: those with an Opioid Use Disorder (OUD) that take buprenorphine for opioid replacement therapy, adults without an Opioid Use Disorder taking buprenorphine, and healthy adults that do not have an Opioid Use Disorder and are not taking buprenorphine.
Being studied: Magnetic Resonance Imaging (MRI); Computer Tasks
Conditions: Opioid Use Disorder; Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria for all groups
- Fluent in English
- Able to give informed consent
- Normal/corrected-to-normal vision and hearing
Inclusion Criteria for Opioid Use Disorder (OUD) group:
- Diagnosis of OUD
- Be actively receiving buprenorphine (BUP) for opioid agonist therapy
- Be free from illicit substance use for at least 2 weeks
- The study will allow stable dose (> 3 months) of commonly prescribed psychiatric medications and some sleep aids (per protocol)
Inclusion Criteria for the BUP control group:
- Taking BUP for chronic pain
- No Substance Use Disorder (including OUD)
- The study will allow stable dose (> 3 months) of commonly prescribed psychiatric medications and some sleep aids (per protocol)
Inclusion Criteria for Healthy participant group:
- Not taking BUP
- Free of any psychiatric or major medical conditions
Exclusion Criteria for all groups
- Pregnancy
- Significant medical or neurologic conditions (e.g., stroke, seizures, multiple sclerosis)
- Actively suicidal
- Contraindication for MRI
- Inability to tolerate small, enclosed spaces without anxiety or unable to fit comfortably in the MRI scanner
- Life history of schizophrenia, learning disability, attention deficit disorder, or pervasive developmental disorder
- Use of substances or prescription medications that could interfere with measures of interest (per protocol)
- Unable to provide informed consent
- Participants who have completed other studies in our lab involving learning and memory assessments with the same/similar tasks used here (HUM00230585, HUM00121812) will not be eligible to complete the current study, due to possible learning/practice effects
Recruiting US locations
University of Michigan
Ann Arbor, MI 48109
Site contact: Aml Almamri · AdversityBrainOUD@med.umich.edu
Study contacts (from the official record)
- Aml Almamri · 734-232-0190 · AdversityBrainOUD@med.umich.edu
Similar studies in Michigan
All healthy volunteers studies in Michigan →- RecruitingHealthy volunteers
Tailoring a Home Supervision Intervention for Latinx Caregivers
Western Michigan University
- Location
- Kalamazoo, MI
- Eligibility basics
- Ages 18–99
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Allen Park, MI + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Prevail Therapeutics
- Location
- Farmington Hills, MI + 1 other US site
- Eligibility basics
- Ages 30–80